Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for QuidelOrtho Corporation (QDEL : NSDQ)

• Company Description    QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. Number of Employees: 7,000

• Price / Volume Information    Yesterday's Closing Price: $85.65 Daily Weekly Monthly 20 Day Moving Average: 305,185 shares Shares Outstanding: 66.63 (millions) Market Capitalization: $5,707.16 (millions) Beta: 0.29 52 Week High: $108.35 52 Week Low: $66.88 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.71% -5.43% 12 Week -0.82% -7.93% Year To Date -0.02% -9.06%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9975 SUMMERS RIDGE ROAD - SAN DIEGO,CA 92121 USA ph: 858-552-1100 fax: 858-453-4338 ir@quidel.com http://www.quidelortho.com

• General Corporate Information    Officers Douglas C. Bryant - President and Chief Executive Officer Kenneth F. Buechler - Chairman of the Board Joseph M. Busky - Chairman of the Board Evelyn S. Dilsaver - Director Edward L. Michael - Director Peer Information QuidelOrtho Corporation (BJCT) QuidelOrtho Corporation (CADMQ) QuidelOrtho Corporation (APNO) QuidelOrtho Corporation (UPDC) QuidelOrtho Corporation (IMTIQ) QuidelOrtho Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 219798105 SIC: 2835 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/23 Next Expected EPS Date: 08/03/23 Share - Related Items Shares Outstanding: 66.63 Most Recent Split Date: (:1) Beta: 0.29 Market Capitalization: $5,707.16 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.20 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $5.18 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/23

• Fundamental Ratios P/E Current FY Estimate: 16.55 Trailing 12 Months: 11.47 PEG Ratio: - Price Ratios Price/Book: 1.14 Price/Cash Flow: 4.70 Price / Sales: 1.84 EPS Growth vs. Year Ago Period: -84.48% vs. Previous Quarter: 2.87% Sales Growth vs. Year Ago Period: -15.58% vs. Previous Quarter: -2.35% ROE 03/31/23 - 10.25 12/31/22 - 20.45 09/30/22 - 30.18 ROA 03/31/23 - 5.73 12/31/22 - 11.86 09/30/22 - 18.45 Current Ratio 03/31/23 - 1.65 12/31/22 - 1.56 09/30/22 - 1.66 Quick Ratio 03/31/23 - 1.07 12/31/22 - 1.04 09/30/22 - 1.04 Operating Margin 03/31/23 - 16.18 12/31/22 - 26.72 09/30/22 - 34.94 Net Margin 03/31/23 - 3.78 12/31/22 - 16.80 09/30/22 - 26.67 Pre-Tax Margin 03/31/23 - 5.64 12/31/22 - 22.53 09/30/22 - 35.24 Book Value 03/31/23 - 74.99 12/31/22 - 74.71 09/30/22 - 72.61 Inventory Turnover 03/31/23 - 2.74 12/31/22 - 2.96 09/30/22 - 2.88 Debt-to-Equity 03/31/23 - 0.48 12/31/22 - 0.49 09/30/22 - 0.52 Debt-to-Capital 03/31/23 - 32.26 12/31/22 - 33.00 09/30/22 - 34.11

Powered by Zacks Investment Research ©